Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Trinity Biotech (NASDAQ: TRIB): Diagnostics Restructuring Meets a Data-Center Pivot

Trinity Biotech, headquartered in Ireland and listed on Nasdaq, develops and markets medical diagnostic products spanning clinical-laboratory and point-of-care testing, including assays for infectious diseases, sexually transmitted infections and diabetes monitoring. In a striking diversification, the company has launched Trinovium, a subsidiary focused on …

Vinay Lochav | 10 September 2026

Nano-X Imaging (NASDAQ: NNOX): Commercial Progress Versus Financial Reality

Nano-X Imaging develops digital X-ray and medical-imaging technology, most notably the Nanox.ARC, a multi-source tomosynthesis system built around its cold-cathode digital X-ray source, along with AI-based image-analysis applications and a teleradiology arm. Through 2026 the company has focused on commercialising that hardware and software. …

Vinay Lochav | 10 September 2026

Accendra Health (NYSE: ACH): What's Behind the Recent Stock Movement in September 2026

Accendra Health began trading on the New York Stock Exchange under the ticker ACH on January 2, 2026, after its predecessor, Owens & Minor, sold its Products & Healthcare Services distributionBusinessand the Owens & MinorBrandon December 31, 2025. What remained, the home-based care operation …

Vinay Lochav | 10 September 2026

Reviva Pharmaceuticals (OTCQB: RVPH): Where Things Stand With Brilaroxazine in September 2026

Reviva is a clinical-stage pharmaceutical company focused on brilaroxazine, an investigational treatment for schizophrenia and other central-nervous-system and inflammatory conditions. A notable structural development came on May 14, 2026, when Reviva's common stock moved from the Nasdaq Capital Market to the OTCQB Venture Market, …

Vinay Lochav | 10 September 2026

Creative Edge Nutrition (OTC:FITX) Carries the Weight of a 2014 Cannabis Frenzy That Never Recovered

Few sub-penny tickers carry as much historical baggage as Creative Edge Nutrition, Inc. (OTC:FITX). The company became a fixture of the 2013-2014 speculative cannabis frenzy, and more than a decade later the stock trades at essentially nothing on the over-the-counter market. The company today …

Nitish Kishor | 10 September 2026

Filana Therapeutics (NASDAQ: FLNA) Edges Higher: What Investors Should Watch Next

A new name, a controversial drug and a regulatory hold make Filana Therapeutics, Inc (NASDAQ: FLNA) one of the more closely watched reinventions in small-cap biotech. Investors who remember the ticker under its former identity will recognise the asset at the centre of the …

Nitish Kishor | 10 September 2026

Forza Innovations (OTC:FORZ) Went Two Years Without an SEC Filing and Nobody Noticed

Few tickers illustrate the outer limits of micro-cap trading quite like Forza Innovations Inc (OTC:FORZ), a Wyoming-incorporated, shell-scale company whose shares change hands at a small fraction of a cent. With the stock effectively flat in the last closing session and priced near the …

Nitish Kishor | 10 September 2026

Forum Markets (NASDAQ:FRMM) Stock: Why Investors Are Reassessing the Tokenization Firm

Forum Markets, Incorporated (NASDAQ:FRMM) has become one of the more unusual small-cap stories on theNasdaqCapital Market this year, and its shares slipped again in early September 2026. The company began life pitching a blockchain platform for tokenizing real-world assets, but it has since pivoted …

Nitish Kishor | 10 September 2026

GlobeImmune's (OTC:GBIM) Yeast-Based Cancer Platform Belongs to an Earlier Immunotherapy Wave

GlobeImmune, Inc. (OTC:GBIM) is a name from an earlier wave of cancer-immunotherapy optimism that has long since faded from active coverage. The developer of the yeast-based Tarmogen platform once ran clinical programs in hepatitis B and oncology, but the stock now trades at the …

Nitish Kishor | 10 September 2026

Evelo Biosciences (OTC:EVLO) Stock: The Real Story Behind a Wound-Down Biotech

When a promising, Flagship Pioneering-founded biotech reaches a sub-penny quote, the percentage swings on any given day become almost meaningless. Evelo Biosciences, Inc. (OTC:EVLO) is a clear example.

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…